Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filemon K Tan

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|June 23, 2006
Autoantibodies against PDGF receptor in sclerodermaFilemon K Tan
Rheumatic Diseases Clinics of North America|July 5, 2003
Systemic sclerosis: the susceptible host (genetics and environment)Filemon K Tan
Current Opinion in Rheumatology|October 15, 2005
Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarraysShervin Assassi, Filemon K Tan
International Journal of Clinical Rheumatology|March 6, 2012
The potential importance of Toll-like receptors in ankylosing spondylitisFilemon K Tan, Kiran Farheen
The Lancet. Rheumatology|April 5, 2021
Flare of rheumatoid arthritis after COVID-19 vaccinationKatherine A Terracina, Filemon K Tan
Current Opinion in Rheumatology|October 22, 2003
Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutationsS Sohail Ahmed, Filemon K Tan
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2021
Letter of RetractionStefania Lenna, Filemon K Tan, Maria Trojanowska
The American Journal of Medicine|May 17, 2002
The complex genetics of sclerodermaS Sohail Ahmed, Filemon K Tan, Frank C Arnett
Rheumatic Diseases Clinics of North America|March 11, 2008
Genetics and genomic studies in scleroderma (systemic sclerosis)Sandeep K Agarwal, Filemon K Tan, Frank C Arnett
The Journal of Surgical Research|February 25, 2014
Secondary use of existing public microarray data to predict outcome for hepatocellular carcinomaCurtis J Wray, Tien C Ko, Filemon K Tan
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|June 23, 2006
Autoantibodies against PDGF receptor in sclerodermaFilemon K Tan
Rheumatic Diseases Clinics of North America|July 5, 2003
Systemic sclerosis: the susceptible host (genetics and environment)Filemon K Tan
Current Opinion in Rheumatology|October 15, 2005
Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarraysShervin Assassi, Filemon K Tan
International Journal of Clinical Rheumatology|March 6, 2012
The potential importance of Toll-like receptors in ankylosing spondylitisFilemon K Tan, Kiran Farheen
The Lancet. Rheumatology|April 5, 2021
Flare of rheumatoid arthritis after COVID-19 vaccinationKatherine A Terracina, Filemon K Tan
Current Opinion in Rheumatology|October 22, 2003
Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutationsS Sohail Ahmed, Filemon K Tan
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2021
Letter of RetractionStefania Lenna, Filemon K Tan, Maria Trojanowska
The American Journal of Medicine|May 17, 2002
The complex genetics of sclerodermaS Sohail Ahmed, Filemon K Tan, Frank C Arnett
Rheumatic Diseases Clinics of North America|March 11, 2008
Genetics and genomic studies in scleroderma (systemic sclerosis)Sandeep K Agarwal, Filemon K Tan, Frank C Arnett
The Journal of Surgical Research|February 25, 2014
Secondary use of existing public microarray data to predict outcome for hepatocellular carcinomaCurtis J Wray, Tien C Ko, Filemon K Tan
Pageof 7